Home›Search›EMBO Molecular Medicine

EMBO Molecular Medicine

Springer Science and Business Media Deutschland GmbH · United Kingdom · Est. 1971

ISSN1757-4676eISSN1757-4684

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

3.277

H-Indexi

184

SNIPi

1.724

Total Worksi

2,339

Total Citationsi

152,034

2yr Mean Citednessi

5.88

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

EMBO Molecular Medicine is a leading open access journal in the field of experimental medicine, advancing translational and biomedical research discoveries worldwide. Published articles include plain-language summaries to emphasise the major findings of a paper and their medical implications for non-specialist readers. Consultative manuscript transfers between EMBO Press journals and with Nature partner journals provide a clear, efficient path to publication. EMBO Molecular Medicine was the first fully open access journal dedicated to publishing highly selective translational research.

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1971

FrequencyTwelve No. A Year

StatusActive (last: 2026)

Total Publications2,339

Publisher OrgSpringer Nature

OA Since2008

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

OA LicenseCC BY, CC0

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1757-4676 / 1757-4684

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

109

8.5k

2019

163

12k

2020

170

9.3k

2021

131

4.6k

2022

148

3.4k

2023

171

2.4k

2024

180

986

2025

148

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Molecular MedicineQ1

Subject Classification

Web of Science Categories

Medicine, Research & Experimental

Scopus Categories

Molecular Medicine

Research Topics (OpenAlex)

Mitochondrial Function and PathologyImmune Cell Function and InteractionCRISPR and Genetic EngineeringRNA modifications and cancerAlzheimer's disease research and treatmentsEpigenetics and DNA MethylationCancer Cells and MetastasisCAR-T cell therapy researchAutophagy in Disease and TherapyGenetics and Neurodevelopmental Disorders

Frequently asked questions about EMBO Molecular Medicine

Is EMBO Molecular Medicine a predatory journal?

PubScope has no integrity flags on record for EMBO Molecular Medicine: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of EMBO Molecular Medicine?

EMBO Molecular Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 5.88.

Is EMBO Molecular Medicine indexed in Scopus and Web of Science?

EMBO Molecular Medicine is indexed in Web of Science, Scopus, DOAJ.